One major challenge is the heterogeneity of cancer, which means that ncRNA expression can vary significantly between different types of cancer and even among patients with the same type of cancer. Another challenge is the limited understanding of the mechanisms by which ncRNAs regulate gene expression. Additionally, the degradation of RNA samples can complicate analysis.
